tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

VIRI

Three new option listings and one option delisting on October 9th
The FlyThree new option listings and one option delisting on October 9th
3M ago
NNE
VIRI
Virios Therapeutics trading halted, news pending
PremiumThe Fly
Virios Therapeutics trading halted, news pending
3M ago
VIRI
Virios Therapeutics target adjusted to $5 from 20c at H.C. Wainwright
PremiumThe Fly
Virios Therapeutics target adjusted to $5 from 20c at H.C. Wainwright
3M ago
VIRI
Virios Therapeutics Transforms into Dogwood Therapeutics
PremiumCompany Announcements
Virios Therapeutics Transforms into Dogwood Therapeutics
3M ago
8K
VIRI
Virios Therapeutics, Wex Pharmaceuticals announce business combination agreement
PremiumThe Fly
Virios Therapeutics, Wex Pharmaceuticals announce business combination agreement
3M ago
VIRI
Virios Therapeutics, Wex Pharmaceuticals announce 25-for-1 reverse stock split
PremiumThe FlyVirios Therapeutics, Wex Pharmaceuticals announce 25-for-1 reverse stock split
3M ago
VIRI
Virios Therapeutics reports Q2 EPS (5c), consensus (6c)
Premium
The Fly
Virios Therapeutics reports Q2 EPS (5c), consensus (6c)
5M ago
VIRI
Virios completes enrollment in IMC-2 Phase 2 Long COVID study
Premium
The Fly
Virios completes enrollment in IMC-2 Phase 2 Long COVID study
6M ago
VIRI
Virios Therapeutics initiated with a Buy rating, $1 price target at Maxim
PremiumThe Fly
Virios Therapeutics initiated with a Buy rating, $1 price target at Maxim
7M ago
VIRI
Virios Therapeutics initiated with a Buy at Maxim
PremiumThe Fly
Virios Therapeutics initiated with a Buy at Maxim
7M ago
VIRI
Virios Therapeutics announces $2.1M offering of common stock
PremiumThe Fly
Virios Therapeutics announces $2.1M offering of common stock
8M ago
VIRI
Virios Therapeutics expects resources to fund operations into 4Q24
PremiumThe Fly
Virios Therapeutics expects resources to fund operations into 4Q24
8M ago
VIRI
Virios Therapeutics reports Q1 EPS (7c) vs. (8c) last year
PremiumThe FlyVirios Therapeutics reports Q1 EPS (7c) vs. (8c) last year
8M ago
VIRI
Virios Therapeutics announces publication of international patent for IMC-2
Premium
The Fly
Virios Therapeutics announces publication of international patent for IMC-2
10M ago
VIRI
Virios Therapeutics expects resources to fund operations into 4Q24
Premium
The Fly
Virios Therapeutics expects resources to fund operations into 4Q24
11M ago
VIRI
Virios Therapeutics reports Q4 EPS (6c) vs. (11c) last year
PremiumThe Fly
Virios Therapeutics reports Q4 EPS (6c) vs. (11c) last year
11M ago
VIRI
Virios Therapeutics announces director fee, management team salary cut
PremiumThe Fly
Virios Therapeutics announces director fee, management team salary cut
11M ago
VIRI
Virios Therapeutics Enacts Salary Cuts and Grants Stock Options
PremiumCompany Announcements
Virios Therapeutics Enacts Salary Cuts and Grants Stock Options
11M ago
8K
VIRI
Virios Therapeutics plans to advance development of IMC-2
PremiumThe Fly
Virios Therapeutics plans to advance development of IMC-2
12M ago
VIRI
Virios reaches alignment with FDA on requirements for IMC-2 advancement
PremiumThe FlyVirios reaches alignment with FDA on requirements for IMC-2 advancement
1y ago
VIRI
Virios Therapeutics reports Q3 EPS (6c) vs. (28c) last year
Premium
The Fly
Virios Therapeutics reports Q3 EPS (6c) vs. (28c) last year
1y ago
VIRI
VIRI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
VIRI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1y ago
VIRI

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >